Encompass Health Corporation

NYSE:EHC

Medical - Care Facilities

Healthcare
$134.93 -1.95%

-$1.95 today

Market cap
$13.24B
Beta
0.59
P/E (TTM)
15.9
EPS (TTM)
$6.14
Dividend yield
0.76%
52W Low $92.77High $127.99

Volume 0.84M

Average 0.92M

EHC Cost of Revenue

Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.

Encompass Health CorporationNYSE: EHC

Cost of Revenue · Q2 FY2026 · quarter ended Jun 2026

Cost of revenue grows in line with its trailing trend

Q2 FY2026 cost of revenue of $886.4M rose 6.7% year over year, in line with the +6.6% change in trailing-twelve-month cost of revenue. Sequentially, it rose 0.5% from the prior quarter. Over 3 fiscal years it compounded at +9.1% a year.

Context

  • Cost of revenue amounted to 56.8% of revenue in FY2025, down 1.7 pp from a year earlier.
  • Cost of revenue increased in 3 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth of +6.7% holds above the trailing-twelve-month pace of +6.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
$886.4M+0.5% QoQ
Last fiscal yearDec 2025
$3.37B+7.3% YoY
LTMJun 2026
$3.48B+6.6% YoY
Cost of Revenue past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+6.7%——
1 year+7.3%——
3-year CAGR+9.1%——
5-year CAGR——
10-year CAGR——

Cost of Revenue history

USD · from the income statement

Latest · FY2025
3.37B USD
Year-over-year change
+7.3%
4-year CAGR
+9.9%

Cost of Revenue vs competitors

How EHC compares with its peers on the latest reported figures

  • EHC's LTM Jun 2026 cost of revenue of $3.48B is the 4th highest of the 9 companies compared; the peer median is $1.81B.
  • Its year-over-year change of +6.6% is the 8th highest of 9, against a peer median of +16.6%.
  • Cost of revenue amounts to 56.1% of revenue for EHC, versus a peer median of 74.9%.
EHC Competitors Peer median
Cost of Revenue for EHC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ENSGThe Ensign Group, Inc.LTM Jun 2026$4.71B +21.3%+19.3%85.9%
OPCHOption Care Health, Inc.LTM Sep 2026$4.69B +4.1%+14.6%81.5%
PACSPACS Group, Inc.LTM Jun 2026$4.46B +11.5%+26.9%80.3%
EHCEncompass Health CorporationLTM Jun 2026$3.48B +6.6%+9.1%56.1%
AVAHAveanna Healthcare Holdings Inc.LTM Oct 2026$1.82B +19.3%+9.7%67.9%
CHEChemed CorporationLTM Jun 2026$1.81B +8.3%+9.0%69.6%
NHCNational HealthCare CorporationLTM Sep 2026$1.08B +16.9%+10.3%68.0%
ADUSAddus HomeCare CorporationLTM Jun 2026$998.65M +16.3%+13.8%67.6%
PNTGThe Pennant Group, Inc.LTM Mar 2026$871.95M +35.1%+25.8%85.2%
Peer median (excluding EHC) $1.81B+16.6%+14.2%74.9%

Competitors are the stored peer set for EHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue4.01B4.35B4.8B5.37B5.94B
Cost of Revenue2.31B2.6B2.82B3.14B3.37B
Gross Profit1.7B1.75B1.98B2.23B2.56B
Gross Margin42.4%40.3%41.3%41.6%43.2%
Research & Development00000
Selling, General & Admin228.5M209M258M266.5M295.2M
Operating Expenses1.04B1.12B1.25B1.37B1.51B
Depreciation & Amortization219.6M243.6M273.9M299.6M327.9M
EBITDA888.9M870.1M1.02B1.19B1.4B
EBITDA Margin22.1%20.0%21.3%22.1%23.7%
Operating Income659.4M630.2M731.8M864.5M1.05B
Operating Margin16.4%14.5%15.2%16.1%17.7%
Interest Income00000
Interest Expense164.3M175.7M143.5M137.4M123.2M
Other Income / Expenses(154.4M)(179.4M)(124.6M)(114.9M)(100.1M)
Income Before Tax505M450.8M607.2M749.6M953M
Pre-Tax Margin12.6%10.4%12.6%14.0%16.1%
Income Tax Expense101.9M100.1M132.2M150.2M192.9M
Net Income412.2M271M352M455.7M566.2M
Net Margin10.3%6.2%7.3%8.5%9.5%
EPS (Basic)4.152.723.544.535.62
EPS (Diluted)4.112.703.474.465.54
Weighted Avg Shares99M99.2M99.5M99.9M100.5M
Weighted Avg Shares (Diluted)100.2M100.4M101.3M102.2M102.2M

Encompass Health Corporation

NYSE:EHC

Intrinsic Alpha fair value

Locked

Current Price

$134.93

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.